SCHEMBL5899490

SCHEMBL5899490

COc1ccc(S(=O)(=O)NCC(=O)c2ccccc2)cc1OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 2/20 0.62
NPSR1 Q6W5P4 1/20 0.58
ALDH1A1 P00352 1/20 0.57
TSHR P16473 1/20 0.57
HSD17B10 Q99714 1/20 0.57
CA12 O43570 1/20 0.57
CA9 Q16790 1/20 0.57
MAPK1 P28482 2/20 0.55
F2 P00734 2/20 0.55
HTT P42858 4/20 0.55
KMT2A Q03164 1/20 0.53
HDAC3 O15379 1/20 0.53
HDAC4 P56524 1/20 0.53
HDAC1 Q13547 1/20 0.53
HDAC7 Q8WUI4 1/20 0.53
HDAC2 Q92769 1/20 0.53
HDAC10 Q969S8 1/20 0.53
HDAC11 Q96DB2 1/20 0.53
HDAC8 Q9BY41 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899446 0.87 KAT6A (0.72) KAT6ANPSR1ALDH1A1TSHRHSD17B10
SCHEMBL5171144 0.82 KMT2A (0.59) NPSR1ALDH1A1TSHRHSD17B10CA12
SCHEMBL5899544 0.78 KAT6A (0.58) KAT6AALDH1A1MAPK1KMT2AHDAC8
SCHEMBL7415584 0.78 SMN1; SMN2 (0.78) NPSR1ALDH1A1TSHRHSD17B10CA12
SCHEMBL5320466 0.77 ALDH1A1 (0.60) KAT6ANPSR1ALDH1A1CA12CA9
SCHEMBL15595362 0.77 HTT (0.56) NPSR1ALDH1A1TSHRMAPK1HTT
SCHEMBL5899429 0.77 KAT6A (0.68) KAT6AALDH1A1KMT2AHDAC8HDAC6
SCHEMBL2941926 0.77 MAPK1 (0.65) NPSR1ALDH1A1TSHRHSD17B10CA12
SCHEMBL4182162 0.77 KMT2A (0.77) NPSR1ALDH1A1TSHRHSD17B10CA12
SCHEMBL23014100 0.76 HSD11B1 (0.66) KAT6AALDH1A1TSHRMAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 KAT6A 2440/4885NPSR1 2055/4885ALDH1A1 139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.